I can’t say enough about how excited I am to be joining with all of you in Minneapolis, Minnesota this year for AVA’s 2022 annual scientific meeting. The D-Team (Design team) is hard at work planning and evaluating topics for the meeting - and from the looks of it we are going to be having some awesome speakers and topics. These include learning with subjects from pre-insertion, insertion, after care thru home care (including adults to neonates) with many well-known experts in the field of vascular accessand brand-new future leaders in our specialty.
Some of you may be asking, how are all the sessions chosen that we see at the scientific meeting? Well, let me tell you about the science behind it. All the submissions that are received through AVA’s Call for Presentations are compiled, blinded, and then assigned to be reviewed by 3 individual D-Team members. They are scored on the following:
•Purpose/goals statement reflect presentation
•Learning objectives are well stated and reflect presentation
•Content description is concise and comprehensive
•Topic / subject is of interest to the AVA audience
•Risk of commercial bias
•Overall submission
If we have new presenters that have never presented previously at an AVA conference, we may have an interview set up as well so that our D-Team can further evaluate the potential speaker and answer any questions they may have about presenting at an AVA meeting.
Total scores are then compiled, and the full D-Team then meets tother to review each submission. Notes from the reviewers are further
discussed and the full team then votes on each submission. The team then plugs each session into an overall schedule. Since the D-Team has already reviewed the surveys from the previous years meeting, they are evaluating sessions to make sure the schedule is covering important topics from the audience’s perspective as well as new topics and speakers.
After two years of learning in the form of virtual (due to Covid restrictions) we now have the potential to meet face to face/mask to mask. Those that have attended before in real time know the rich experience and recharge of our vascular access batteries by meeting face-to-face. Experiencing a 30/60-minute breakout session with your peers, general session, perusing the poster presentations or exploring the newest products in the form of our Exhibit Hall - where you can talk with a live person (and see the newest technologies and medical equipment) you will find an amazing experience. Another great opportunity that we all find with the face-to-face meetings is the opportunity to network with each other and put faces to the names we see on various social media group pages every day. Networking is a key component to the experience at AVA’s scientific meeting and you should fully take advantage. Many of the current experts are there and extremely approachable to meet and talk. All I can say is you will be hooked after your first meeting.
When you start to feel the need for something nonvascular access related take a trip to the local areas with your newfound vascular friends. In Minneapolis you will find places such as St. Paul’s Grand Avenue shopping or Midtown Global Market for a Juicy Lucy burger to satisfy your palate and then complete your night at Guthrie Theater or First Avenue for live music. (https://www.minneapolis.org/visitor-information/)
I am extremely honored to be your D-Team Chair this year to help make this a great comeback to a live event (with some virtual components). I can’t say enough about the team of professionals I am working with (and the amount of time they are willing to give) to make this a phenomenal experience for all. I sincerely want to thank each and every one of them for all they are doing and what we are creating. I also can’t say enough about AVA as an organization bringing this form of education to us - It should be a great time with something for all vascular access professionals.
Warren McGlauflin, RN, BS, VA-BCTM, Chair - D-Team, AVA Scientific Meeting 2022
THE ASSOCIATION FOR VASCULAR ACCESS (AVA) CONGRATULATES STEPHANIE PITTS, DNP, RN, CPN, VA-BCTM, NEA-BC ON BEING THE 2022 RECIPIENT OF THE SUZANNE LAVERRE HERBST AWARD FOR EXCELLENCE IN VASCULAR ACCESS.
The highest honor bestowed by AVA, the Herbst Award is granted annually to a member exemplifying AVA’s mission, including being a recognized expert in vascular access, for making significant contributions to the art and science of vascular access, and for positively affecting patient outcomes in vascular access.
Throughout her career, Dr. Stephanie Pitts has been a leading innovator in Pediatric Vascular Access, designing products and programs aimed at improving knowledge and efficacy in the field of vascular access. Stephanie developed and implemented the Vascular Access program at St Joseph’s Children’s Hospital, contributing to improved quality of care. As an industry leader, Stephanie has enhanced clinical vascular access expertise in medical device sales through the development of evidence-based clinical education and support programs at two international medical device companies. Finally, Dr. Pitts has been a leader in collaboration, connecting industry and clinical leaders to develop evidencebased vascular access education aimed at improving outcomes.
Dr. Pitts has published within the Journal of the Association for Vascular Access (JAVA) on pediatric ethanol locking and pediatric vascular access program best practices, as well as two AVA position papers. Additionally, Stephanie contributed to the miniMAGIC study on appropriate pediatric device selection in collaboration with the AVATAR group. Most recently, she co-developed the minimum competency guidelines for pediatric PIVC insertion and care. Her DNP project was a continuation of this work, developing these guidelines into online modules. This will change the way we educate and provide pediatric vascular access care.
Stephanie has been an active member of AVA since 2008, and served on the board of directors from 2018-19. She is also a member of GulfVAN, serving as their president from 2009-2013. Most notably, she helped to develop AVA’s Pediatric Special Interest Group (SIG) and served as the SIG president from 2013-2016. Dr. Pitts has also presented at every AVA consecutively since 2010.
STEPHANIE PITTS, DNP, RN, CPN, VA-BC™ , NEA-BC
mission and values of our organization. This year AVA and the Pediatric Neonatal Special Interest Group (PediNeoSIG) recognizes Mary Beth Hovda Davis, as the 2022 Dr. Janet Pettit Scholar.
DAVID M. MARKLE JR., RN, VA-BC™, EMT-B
MARY BETH HOVDA DAVIS, MSN, RN, VA-BC™
The Association for Vascular Access (AVA) created the Dr. Janet Pettit Scholar recognition to honor and commemorate outstanding contributions to the art and science of neonatal and pediatric vascular access. Dr. Pettit epitomized the
Ms. Davis is a Nursing Practice Leader for the Pediatric Vascular Access service at The University of Iowa Stead Family Children’s Hospital in Iowa City, Iowa, where she has practiced for 15 years. From the national and global perspectives, Ms. Davis has led the cutting edge of pediatric vascular access education and practice with pacesetting publications. As the lead author on the position paper for minimum education and training for pediatric and neonatal intravenous insertion, she provided the foundation for AVA to develop a foundational eLearning course, a first in this specialty. She has collaborated globally to explore vascular access practice in children and changed
practice to reduce patient harm through her distinct scholarly contributions. She has shared her research and practice innovations through numerous national and virtual presentations. Her nursing and professional achievements have been recognized through scholarships and awards including being named a Corridor Business Journal Forty under 40 Honoree.
As a former PediNeoSIG Chair, PediNeoSIG Liaison for the AVA D-Team, current PediNeoSIG Chair Advisor, and engaged PedNeoSIG member for 14 years, Ms. Davis has provided visionary leadership for pediatric and neonatal clinicians in the area of vascular access with an extraordinary heart for collaboration and mentorship.
In honor of the life work of Dr. Janet Pettit, please join AVA and the PediNeoSIG as we congratulate Ms. Mary Beth Davis as the 2022 Dr. Janet Pettit Scholar.
THANK YOU FOR YOUR EXCEPTIONAL LEADERSHIP WITHIN YOUR ORGANIZATION AND YOUR CONTRIBUTIONS TO VASCULAR ACCESS IN YOUR COMMUNITY.
Are you planning to join us at AVASM22, either in-person or virtually?
Be sure to plan out your schedule so you don't miss your favorite sessions! You can download the event app here, search sessions, add them to your schedule, and even export to your personal calendar app for automated reminders.
To start you off, we've curated a short list of many amazing educational sessions coming to AVASM22. All general sessions that are livestreamed will also be available for re-play immediately after the session ends; so for our virtual attendees, you don't have to worry about missing anything!
TO SUCCEED, WE NEED TO UNDERSTAND WHY WE SOMETIMES FAIL. Dr. Steve offers a hilarious, highly interactive masterclass in missing the obvious, distressing yourself, and procrastinating like a pro! Drawing inspiration from a ping-pong ball, a dead housefly, and Shania Twain, he’ll make you laugh harder during this session than you ever thought possible at a healthcare meeting.
Then, after this roller coaster ride of “grab ’em by the eyeballs” fun, you’ll learn…
1.Inside Out Thinking: Learn step-by-step tactics for reframing challenges and shattering blind spots.
2.The Emotion Equation: Learn how to recognize emotional triggers, unhook from frustrating situations and stay focused, optimistic and productive under pressure.
3.Resilience Boosting: How to handle the tsunami of major adversity, and also the day-to-day hiccups and lesser turmoils that are part of our daily lives.
4.Effective, science-smart tactics explained in simple terms so that you can put them to work immediately; powerful and time- effcient.
Expect a speech that’s riveting, provocative, and explosively funny...and then watch Dr. Steve exceed your expectations.
•Learn step-by-step tactics for reframing challenges and shattering blind spots
•Learn how to recognize emotional triggers, unhook from frustrating situations and stay focused, optimistic and productive under pressure
•Learn how to handle the tsunami of major adversity, and also the day-to-day hiccups and lesser turmoil’s that are part of our daily lives
Transforming our specialty is critical to be on top of the rapid changes in healthcare today. We will identify key transformations that are needed for vascular access to thrive in the healthcare ecosystem into the next decade.
Learning Objectives:
•Review the history of vascular access and the impact on practice today.
•Identify and discuss what we must consider how to advance vascular access for the next decade.
•Discuss why transforming our specialty matters and your individual role.
DON’T MISS THE LAST DAY OF AVASM22! You can earn up to 6 CEs by staying through the last session, “The Use of Non-Antibiotic Antimicrobial to Control Biofilm Formation”. In this session, attendees learn the importance of non-antibiotic antimicrobials in the fight against antibiotic-resistant microorganisms.
Learning Objectives:
•Understand what microbial biofilms are and how they contribute to medical problems with catheters.
•Recognize the dangers of antimicrobial resistance and understand why we need alternatives to antibiotics.
•Observe the positive impact of tetrasodium EDTA at killing microorganisms and combining with other non-antibiotic antimicrobials.
more about the microbial communities that can colonize central venous catheters.
Presented by Michelle L. Hawes, RN, DNP, CRNI®, VA-BC™ and Co-presenters: Mark Weber, RN, CPNP-AC, FCCM; Elizabeth Sharpe, DNP, APRN, NNP-BC, VA-BC™, FAANP, FAAN; Jon Bell, MSN, RN, VA-BC™; Timothy R. Spencer, DipAppSci, BHealth, ICCert, RN, APRN, VA-BC™
12:30 PM – 2:00 PM CST
3, 2022
LOCATION: BALLROOM (LEVEL 1) CE: 1
RESEARCH ON PATIENT SAFETY IN VASCULAR ACCESS IS A PRIMARY MISSION FOR THE AVA FOUNDATION. Four experts in research and publication will conduct a review of current studies. Each presenter will discuss recently published research and its impact on current practice. The appraisal of these chosen studies will assist the participant in understanding levels of research, quality of research, gaps in current vascular access studies, and significant publication elements. Following the presentation, the panel will be available to answer questions from the participants.
Learning Objectives:
•List recently published research that impacts current practice.
•Define key components of a research study.
•Identify at least one possible gap in vascular access research.
•Describe major milestones in publishing research.
AVA IS PLEASED SHARE WITH YOU THE RECENT ISSUE OF HEALTHCARE HYGIENE MAGAZINE.
AVA believes creating alliances with like organizations based on mutually beneficial initiative presence, awareness and endorsements will enhance our ability to achieve our mission and vision.
The September issue of Healthcare Hygiene magazine with a focus on vascular access-related infection prevention is now available at: https://www. healthcarehygienemagazine.com/monthly-issues/
Clockwise from bottom left: Michelle L. Hawes, Elizabeth Sharpe, Mark Weber, Timothy R. Spencer, Jon Bell
FORMATION in the context of peripheral intravenous cannulation. Relevant introduction to blood clotting will be provided and the impact of local injury, fluid infusion forces, medication toxicity/ irritation on the blood and blood vessels will be covered. The latest experimental data will then be presented,focusingonunderstandingtheimpactof PIVCgauge and infusion rate on thrombus formation will be provided, including state-of-the-art threedimensional thrombus imaging to demonstrate the location and volume of blood clots formed.
•Describe the normal structure and functions of veins.
•Describe the acute response of the vein and blood to the insertion of a peripheral intravenous catheter.
•State the prevalence of PIVC thrombosis, in various patient groups.
•Explain how insertion and maintenance of PIVCs might lead to local thrombosis and the order of events that occur leading to this.
•Understand the
of PIVC function.
to
Minimize cost and eliminate secondary cleaning procedures with UltraDrape® from Parker Laboratories. UltraDrape is cost-efficient compared to the alternative use of sterile gels and covers, while its inventive design allows an aseptic, no touch procedure. UltraDrape is manufactured with a film layer which provides an effective barrier against all viruses and bacteria as small as 20nm.
UltraDrape… the first-of-its-kind, sterile barrier and securement dressing uniquely designed for UGPIV.
Andrew C. Bulmer and Peter J. Carr
The AVA Board wants to meet you! The Annual Scientific Conference is the perfect opportunity to chat with your elected Board, discuss concerns, or make suggestions.
Let us welcome you properly!
After registering and visiting the Membership Engagement Committee’s First-Timers Lounge, stop by the AVA booth to pick up
Both the AVA Resource Guide and the new Pediatric PICC guide by AVA’s PediNeoSIG will be available! Both print and digital formats will be in stock at steep discounts while supplies last. Prices only valid in-person at AVASM22.
All information on CE, CME, ASRT, VA-BC and CRNI credits can be found under the “EVAL” button at the bottom of the event app.
Attendees have until November 14, 2022 to claim CE credits. In order to download the CE certificate, attendees must complete session and event evaluations.
For all other credits, click “EVAL” and then select “Accreditation Information” to access links.
AVA, The Association for Vascular Access, is a notfor-profit multidisciplinary professional organization uniquely positioned as the leader in vascular access education and research. Its mission is to improve patient safety, comfort and outcomes, define the vascular access specialty, promote a favorable public policy environment, optimize professionals’ knowledge and skills, share best practices, and promote research in vascular access. AVA’s membership includes clinicians from many disciplines including nursing, medicine, radiology, respiratory therapy, pharmacy, as well as consumers, professionals from industry, education, research, and others with an interest or specialization in vascular access and related fields.
Meeting attendees come from many countries and include professionals from:
Interventional Radiology
Oncology
Surgery
Education and Training
Critical Care
Home Infusion
Home Care
Hematology
2023 marks AVA’s 36th Annual Scientific Meeting with at least 1,300 attendees, which include 60–70 industry partners. The meeting site is in Portland, Oregon. AVA demonstrates its leadership role in the art and science of vascular access. This four-day conference (October 14-17, 2023) provides attendees with opportunities to participate in educational sessions, hands-on training, facilitated discussion, and networking.
General Sessions focus on development of the vascular access specialty, clinical research, professional development, technological advances, and evidence-based practice.
Breakout Sessions will offer small group presentations emphasizing subjects of interest for the vascular access specialist and related disciplines; abstract and poster presentations allow participants to share original research, education projects and clinical innovations.
Platinum Showcases and Exhibits afford participants, corporate members, and exhibitors the opportunity to learn from each other, design and apply new technologies, science, and techniques in the most effective ways.
With separate registration fees, an additional day of Pre-Meeting Workshops (October 13, 2023) offers in-depth exploration of topics of critical importance to the vascular access community.
1) Professionals who wish to submit a Topic for Presentation
2) Recommendations for speakers and/or topics to be included in the Scientific Meeting
• Participation and submission of topic suggestions is NOT limited to AVA members
• Topics should address the general or specific interests of AVA members and meeting participants keeping in mind that AVA is an organization of clinicians, healthcare specialties, and industry/ corporate professionals involved in vascular access and related fields
• Presentations must avoid any semblance of commercialism
• General Sessions are limited to 60 minutes in length
• Breakout Sessions may be scheduled from 30 to 60 minutes in length at the discretion of the selection committee
• Hands-On Workshops may be scheduled for a full day (8 hours) or for a half day (4 hours)
Radiology
Pediatrics and Neonatology
Nephrology and Dialysis
• Anesthesiology
Infectious Disease
• A topic submitter may submit more than one topic, but please note that each speaker may be limited to presenting at only one invited session and one poster/oral abstract as the principal author
Infection Prevention
Vascular Access
Research and Development
Sales and Marketing
Engineering
• AVA values diversity, inclusion, and professional mentoring among its membership and promotes these values in its topic and speaker selection processes
• AVA reserves the right to solicit additional and/or new speakers for any proposed topic
The information listed below is required to complete the submission process.
Each submission is reviewed by program committee members who score the key elements based on how closely the given criteria are met.
The information listed below is required to complete the submission process. Each submission is reviewed by program committee members who score the key elements based on how closely the given criteria are met.
Presentation Title:
Content Description:
Use key words that describe the specific topic and content of the abstract. Catch phrases can be used but need to include a reference to the topic. For example, “Making a Difference” may get attention but does not suggest what the abstract is about. By adding a specific reference to the abstract subject matter, the abstract title becomes clearer; i.e., “Making a Difference: Ace Inhibitors in Hypertensive Patients.”
Presentation Title:
Use key words that describe the specific topic and content of the abstract. Catch phrases can be used but need to include a reference to the topic. For example, “Making a Difference” may get attention but does not suggest what the abstract is about. By adding a specific reference to the abstract subject matter, the abstract title becomes clearer; i.e., “Making a Difference: Ace Inhibitors in Hypertensive Patients.”
Target Audience:
What population is this session designed to benefit most?
Target Audience:
What population is this session designed to benefit most?
Level of experience of the target audience: Basic, Intermediate, Advanced
Level of experience of the target audience: Basic, Intermediate, Advanced
What type of presentation is this?
General Session Breakout Session* Hands-On Workshop
What type of presentation is this? General Session Breakout Session* Hands-On Workshop
*Breakout Sessions may be scheduled from 30 to 60 minutes in length at the discretion of the selection committee.
*Breakout Sessions may be scheduled from 30 to 60 minutes in length at the discretion of the selection committee.
Prerequisite:
Include the minimum knowledge and/or skills required to most benefit from this session.
Prerequisite:
Include the minimum knowledge and/or skills required to most benefit from this session.
Purpose/Goals:
This statement should be the most important primary information you want to convey for the abstract. This should be one or two sentences. The title should not be repeated.
This statement should be the most important primary information you want to convey for the abstract. This should be one or two sentences. The title should not be repeated.
Has this presentation been given before? Where?
Has this presentation been given before? Where?
Learning Objectives /Outcomes:
Learning Objectives /Outcomes:
Minimum of three objectives are required. Provide three to five outcomes that complete the statement: “By the end of this session the participant will be able to”. Do not type this statement in the text box when entering each of your outcomes.
Minimum of three objectives are required. Provide three to five outcomes that complete the statement: “By the end of this session the participant will be able to” Do not type this statement in the text box when entering each of your outcomes.
Content Description:
The content description should be concise yet comprehensive. Ask yourself as you are reading the session description, “As an attendee, do I know what this abstract is about and would I want to attend?” Ask a colleague to read it as well while considering the same question. (max. 1,000 characters including spaces)
The content description should be concise yet comprehensive. Ask yourself as you are reading the session description, “As an attendee, do I know what this abstract is about and would I want to attend?” Ask a colleague to read it as well while considering the same question. (max. 1,000 characters including spaces)
Additional Text:
Additional Text:
Any additional text that expands the content description to be used for the review process. This narrative is your opportunity to provide a convincing overview of the value of your proposed session. If the reviewers cannot clearly understand what this session is about, your odds of having your abstract selected are greatly reduced. Expansion of the content description must be written in a brief, well-organized, and focused manner. In one paragraph the potential speaker should have written a narrative that: 1. Identifies the key topics that will be addressed 2. Describes any special learning activities, such as case study analysis, audience participation, or interactive discussion.
Any additional text that expands the content description to be used for the review process. This narrative is your opportunity to provide a convincing overview of the value of your proposed session. If the reviewers cannot clearly understand what this session is about, your odds of having your abstract selected are greatly reduced. Expansion of the content description must be written in a brief, well-organized, and focused manner. In one paragraph the potential speaker should have written a narrative that: 1. Identifies the key topics that will be addressed 2. Describes any special learning activities, such as case study analysis, audience participation, or interactive discussion.
Speaker Contact Information, CV/Resume, Presentation Experience, and Availability Over Meeting Dates.
Speaker Contact Information, CV/Resume, Presentation Experience, and Availability Over Meeting Dates.
Contracts are signed only with the primary presenter. Only the Primary Presenter may be eligible for any speaker incentives. All presenters must be aware that this application is being submitted.
Contracts are signed only with the primary presenter. Only the Primary Presenter may be eligible for any speaker incentives. All presenters must be aware that this application is being submitted.
Some applicants will be contacted by an AVA 2023 Annual Meeting Design Team Member for a phone interview between February and March of 2023 to discuss the presentation submission. Please try to return messages promptly. The interview is an integral part of the submission review process. Failure to participate, or be available for an interview may result in the elimination of the submission from the review process.
Some applicants will be contacted by an AVA 2023 Annual Meeting Design Team Member for a phone interview between February and March of 2023 to discuss the presentation submission. Please try to return messages promptly. The interview is an integral part of the submission review process. Failure to participate, or be available for an interview may result in the elimination of the submission from the review process.
The program will be selected by April 2023. Applicants will receive notice by email.
The program will be selected by April 2023 Applicants will receive notice by email.
